US Patent Issued to INTERVET on Aug. 11 for "Caninized rat antibodies to canine interleukin-31 receptor alpha" (California, Nebraska, New Jersey Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,751, issued on Aug. 11, was assigned to INTERVET INC. (Rahway, N.J.).

"Caninized rat antibodies to canine interleukin-31 receptor alpha" was invented by Mohamad Morsey (Omaha, Neb.), Yuanzheng Zhang (Somerset, N.J.) and Anasuya Saha (Freemont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides caninized rat antibodies to canine IL-31 receptor alpha that have a high binding affinity for canine IL-31 receptor alpha, and that can block the binding of canine IL-31 to canine IL-31 receptor alpha. The present invention further provides the use of the antibodies for the treatment of atopic dermatitis in dogs."

The patent ...